Patent directory · USPTO A61K / A61P
Patents matching “REGENERON PHARMACEUTICALS, INC.”
837 pharma patents match "REGENERON PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 837 pharmaceutical patents matching "REGENERON PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11666658
Rifamycin analogs and antibody-drug conjugates thereof
granted -
US 11655291
Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or activin A
granted -
US 11655286
Anti-PcrV antibodies that bind PcrV, compositions comprising anti-PcrV antibodies, and methods of use thereof
granted -
US 11649273
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11642390
Method of treatment with a fusion protein comprising apelin and an anti-APLNR antibody
granted -
US 11640848
Immunotherapy methods for patients whose tumors carry a high passenger gene mutation burden
granted -
US 11634480
Human antibodies to GREM1
granted -
US 11633501
Anti-STEAP2 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind STEAP2 and CD3, and uses thereof
granted -
US 11629195
Anti-IL2 receptor gamma antigen-binding proteins
granted -
US 11622547
Genetically modified mouse that expresses human albumin
granted -
US 11608381
Methods of treatment using a leptin receptor agonist antibody
granted -
US 11608380
Anti-EGFRvIII antibodies and uses thereof
granted -
US 11603413
Anti-TMPRSS2 antibodies and antigen-binding fragments
granted -
US 11603408
Methods for treating skin infection by administering an IL-4R antagonist
granted -
US 11603407
Stable antibody formulation
granted -
US 11596690
Stabilized formulations containing anti-IL-33 antibodies
granted -
US 11596635
Pharmaceutical compositions comprising macrolide diastereomers, methods of their synthesis and therapeutic uses
granted -
US 11594302
High resolution allele identification
granted -
US 11590223
Dosing strategy that mitigates cytokine release syndrome for therapeutic antibodies
granted -
US 11584966
Piezo type mechanosensitive ion channel component 1 (PIEZO1) variants and uses thereof
granted -
US 11576356
Genetically modified non-human animals and methods of use thereof
granted -
US 11579150
Methods for characterizing disulfide bonds
granted -
US 11578135
Multispecific antigen-binding molecules binding to a target and an internalizing effector protein that is CD63 and uses thereof
granted -
US 11578127
Anti-Fc epsilon-R1 alpha (FcεR1α) antibodies, bispecific antigen-binding molecules that bind FcεR1α and CD3, and uses thereof
granted